Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 13, 2025
Efficacy, safety, and multi-omics analysis of pembrolizumab combined with nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: A single-arm phase 2 studyLin Gui, Xinrui Chen, Wen Zhang, et al.
Chronic Diseases and Translational Medicine|September 10, 2021
Recombinant human thrombopoietin prior to mobilization chemotherapy facilitates platelet recovery in autologous transplantation in patients with lymphoma: Results of a prospective randomized studyHongnan Mo, Peng Liu, Yan Qin, et al.
Asia-Pacific Journal of Clinical Oncology|January 20, 2017
Comparison of CBV, BEAM and BEAC high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation in non-Hodgkin lymphoma: Efficacy and toxicityYouwu Shi, Peng Liu, Shengyu Zhou, et al.
Molecular & Cellular Proteomics : MCP|March 21, 2024
High-Throughput Antigen Microarray Identifies Longitudinal Prognostic Autoantibody for Chemoimmunotherapy in Advanced Non-Small Cell Lung CancerLiyuan Dai, Qiaoyun Tan, Lin Li, et al.
International Journal of Cancer|May 14, 2020
Molecular profiling of Chinese R-CHOP treated DLBCL patients: Identifying a high-risk subgroupShiyu Jiang, Yan Qin, Hongxin Jiang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 19, 2014
Clinical features, survival and prognostic factors of primary testicular diffuse large B-cell lymphomaBo Jia, Yuankai Shi, Mei Dong, et al.
Hematology (Amsterdam, Netherlands)|April 15, 2016
Comparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomasBo Jia, Shaoxuan Hu, Jianliang Yang, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2020
Safety and clinical efficacy of toripalimab, a PD-1 mAb, in patients with advanced or recurrent malignancies in a phase I studyJianliang Yang, Lihou Dong, Sheng Yang, et al.
BMJ Open|June 3, 2019
Evaluating stress, satisfaction and the associated influencing factors of participants in cancer clinical trials: a cross-sectional study in ChinaShiyu Jiang, Peng Liu, Sheng Yang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 7, 2015
Addition of rituximab is not associated with survival benefit compared with CHOP alone for patients with stage I diffuse large B-cell lymphomaBo Jia, Yuankai Shi, Suyi Kang, et al.
Pageof 8